Pfizer said earlier on Monday it had made a 58.8
billion pounds ($98.9 billion) bid approach to AstraZeneca in
January and had contacted its British rival again on April 26
seeking further discussions about a takeover.
"In this discussion, the Chairman of Pfizer did not make a specific
proposal regarding an offer to acquire AstraZeneca," Astra said.
The British company said it had considered the request for talks,
but without a specific and attractive proposal, it had deemed it
inappropriate to engage in discussions with Pfizer.
"The board remains confident in the ongoing execution of
AstraZeneca's strategy as an independent company and that its
successful delivery will create significant value for shareholders,"
(Reporting by Kate Holton; editing by Brenda Goh)
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.